PAMELA WINN: Open Payments
NPI 1235584772 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 18 payments from 7 companies in 2025. Trend: 2023 $517 · 2024 $184 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $203 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $113 |
| Lilly USA, LLC | 3 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $45 |
| Exact Sciences Corporation | 1 | $21 |
| PFIZER INC. | 1 | $20 |
| Phadia US Inc. | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, XIFAXAN, MOUNJARO, Cologuard Collection Kit, NURTEC ODT, JARDIANCE, ImmunoCAP.
Industry payments across NV — which companies pay providers there.
